BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15293989)

  • 1. Human integrin alphavbeta5: homology modeling and ligand binding.
    Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
    J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.
    Fujita M; Zhu K; Fujita CK; Zhao M; Lam KS; Kurth MJ; Takada YK; Takada Y
    J Biol Chem; 2015 Jan; 290(1):259-71. PubMed ID: 25398877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the extracellular segment of integrin alpha Vbeta3.
    Xiong JP; Stehle T; Diefenbach B; Zhang R; Dunker R; Scott DL; Joachimiak A; Goodman SL; Arnaout MA
    Science; 2001 Oct; 294(5541):339-45. PubMed ID: 11546839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer.
    Böger C; Warneke VS; Behrens HM; Kalthoff H; Goodman SL; Becker T; Röcken C
    Gastric Cancer; 2015 Oct; 18(4):784-95. PubMed ID: 25315085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand.
    Luo BH; Springer TA; Takagi J
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2403-8. PubMed ID: 12604783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment.
    Xiong JP; Mahalingham B; Alonso JL; Borrelli LA; Rui X; Anand S; Hyman BT; Rysiok T; Müller-Pompalla D; Goodman SL; Arnaout MA
    J Cell Biol; 2009 Aug; 186(4):589-600. PubMed ID: 19704023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand recognition by the I domain-containing integrins.
    Dickeson SK; Santoro SA
    Cell Mol Life Sci; 1998 Jun; 54(6):556-66. PubMed ID: 9676575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Discovery of a Novel Class of Small-Molecule Pure Antagonists of Integrin αVβ3.
    Sen S; Spasic A; Sinha A; Wang J; Bush M; Li J; Nešić D; Zhou Y; Angiulli G; Morgan P; Salas-Estrada L; Takagi J; Walz T; Coller BS; Filizola M
    J Chem Inf Model; 2022 Nov; 62(22):5607-5621. PubMed ID: 36279366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key interactions in integrin ectodomain responsible for global conformational change detected by elastic network normal-mode analysis.
    Matsumoto A; Kamata T; Takagi J; Iwasaki K; Yura K
    Biophys J; 2008 Sep; 95(6):2895-908. PubMed ID: 18515366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin αVβ3 and PAR2.
    Majewski MW; Gandhi DM; Holyst T; Wang Z; Hernandez I; Rosas R; Zhu J; Weiler H; Dockendorff C
    RSC Med Chem; 2020 Aug; 11(8):940-949. PubMed ID: 33479689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the first potent and selective α
    Lippa RA; Barrett J; Pal S; Rowedder JE; Murphy JA; Barrett TN
    Eur J Med Chem; 2020 Dec; 208():112719. PubMed ID: 32865176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular View on the
    D'Amore VM; Donati G; Lenci E; Ludwig BS; Kossatz S; Baiula M; Trabocchi A; Kessler H; Di Leva FS; Marinelli L
    J Chem Inf Model; 2023 Oct; 63(20):6302-6315. PubMed ID: 37788340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review.
    Tvaroška I; Kozmon S; Kóňa J
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field.
    Ludwig BS; Kessler H; Kossatz S; Reuning U
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Targeting of αvβ5 Integrin in HepG2 Cell Line by RGDechi15D Peptide.
    Capasso D; Del Gatto A; Comegna D; Russo L; Fattorusso R; Saviano M; Di Gaetano S; Zaccaro L
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.
    Kim H; Wrann CD; Jedrychowski M; Vidoni S; Kitase Y; Nagano K; Zhou C; Chou J; Parkman VA; Novick SJ; Strutzenberg TS; Pascal BD; Le PT; Brooks DJ; Roche AM; Gerber KK; Mattheis L; Chen W; Tu H; Bouxsein ML; Griffin PR; Baron R; Rosen CJ; Bonewald LF; Spiegelman BM
    Cell; 2018 Dec; 175(7):1756-1768.e17. PubMed ID: 30550785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frustrated endocytosis controls contractility-independent mechanotransduction at clathrin-coated structures.
    Baschieri F; Dayot S; Elkhatib N; Ly N; Capmany A; Schauer K; Betz T; Vignjevic DM; Poincloux R; Montagnac G
    Nat Commun; 2018 Sep; 9(1):3825. PubMed ID: 30237420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.
    Sutherland M; Gordon A; Shnyder SD; Patterson LH; Sheldrake HM
    Cancers (Basel); 2012 Oct; 4(4):1106-45. PubMed ID: 24213501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation.
    Mas-Moruno C; Rechenmacher F; Kessler H
    Anticancer Agents Med Chem; 2010 Dec; 10(10):753-68. PubMed ID: 21269250
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.